Evidence map›Paper›PMID 20201986›Full record

ArticleImmunology2010

An antibody profile of systemic lupus erythematosus detected by antigen microarray.

Ittai Fattal, Noam Shental, Dror Mevorach, Juan-Manuel Anaya, Avi Livneh, Pnina Langevitz, Gisele Zandman-Goddard, Rachel Pauzner, Miriam Lerner, Miri Blank and 6 more

Abstract read
In one paragraph

Article in Immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ittai FattalDepartment of Nephrology, Rabin Medical Center, Petach Tikva, Israel.
Noam Shental
Dror Mevorach
Juan-Manuel Anaya
Avi Livneh
Pnina Langevitz
Gisele Zandman-Goddard
Rachel Pauzner
Miriam Lerner
Miri Blank
Maria-Eugenia Hincapie
Uzi Gafter
Yaakov Naparstek
Yehuda Shoenfeld
Eytan Domany
Irun R Cohen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

summaryPatients with systemic lupus erythematosus (SLE) produce antibodies to many different self-antigens. Here, we investigated antibodies in SLE sera using an antigen microarray containing many hundreds of antigens, mostly self-antigens. The aim was to detect sets of antibody reactivities characteristic of SLE patients in each of various clinical states--SLE patients with acute lupus nephritis, SLE patients in renal remission, and SLE patients who had never had renal involvement. The analysis produced two novel findings: (i) an SLE antibody profile persists independently of disease activity and despite long-term clinical remission, and (ii) this SLE antibody profile includes increases in four specific immunoglobulin G (IgG) reactivities to double-stranded DNA (dsDNA), single-stranded DNA (ssDNA), Epstein-Barr virus (EBV) and hyaluronic acid; the profile also includes decreases in specific IgM reactivities to myeloperoxidase (MPO), CD99, collagen III, insulin-like growth factor binding protein 1 (IGFBP1) and cardiolipin. The reactivities together showed high sensitivity (> 93%) and high specificity for SLE (> 88%). A healthy control subject who had the SLE antibody profile was later found to develop clinical SLE. The present study did not detect antibody reactivities that differentiated among the various subgroups of SLE subjects with statistical significance. Thus, SLE is characterized by an enduring antibody profile irrespective of clinical state. The association of SLE with decreased IgM natural autoantibodies suggests that these autoantibodies might enhance resistance to SLE.

Indexed as

Protein Array Analysis12E7 AntigenAdultAntibodies, AnticardiolipinAntibodies, AntinuclearAntigens, CDAutoantibodiesCell Adhesion MoleculesCollagen Type IIIDown-RegulationFemaleHerpesvirus 4, HumanHumansHyaluronic AcidImmunoglobulin GImmunoglobulin M12E7 AntigenAntibodies, AnticardiolipinAntibodies, AntinuclearAntigens, CDAutoantibodiesCD99 protein, humanCell Adhesion MoleculesCollagen Type IIIHyaluronic AcidIGFBP1 protein, humanImmunoglobulin GImmunoglobulin MInsulin-Like Growth Factor Binding Protein 1Peroxidase

Identifiers

PMID20201986
PMCPMC2913213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.